Home >> Research Area >> DNA Damage/DNA Repair

DNA Damage/DNA Repair

DNA damage is an alteration in the chemical structure of DNA, such as a break in a strand of DNA, a base missing from the backbone of DNA, or a chemically changed base as 8-OHdG. Damage to DNA that occurs naturally can result from metabolic or hydrolytic processes. Metabolism releases compounds that damage DNA including reactive oxygen species, reactive nitrogen species, reactive carbonyl species, lipid peroxidation products and alkylating agents, among others, while hydrolysis cleaves chemical bonds in DNA.DNA repair is a collection of processes by which a cell identifies and corrects damage to the DNA molecules that encode its genome. In human cells, both normal metabolic activities and environmental factors such as radiation can cause DNA damage, resulting in as many as 1 million individual molecular lesions per cell per day.

Products for DNA Damage/DNA Repair

  1. Cat.No. Product Name Information
  2. BCC5090 Flumequine Flumequine (R-802) is a quinolone antibiotic, and acts as a topoisomerase II inhibitor, with an IC50 of 15 μM (3.92 μg/mL). Flumequine
  3. BCC1173 Cladribine Cladribine is an adenosine deaminase inhibitor used to treat hairy cell leukemia and multiple sclerosis. Cladribine
  4. BCC1174 Dacarbazine Dacarbazine(DTIC-Dome; DTIC) is an antineoplastic agent. Dacarbazine
  5. BCN5499 Genistein Genistein, a soy isoflavone, is a multiple tyrosine kinases (e.g., EGFR) inhibitor which acts as a chemotherapeutic agent against different types of cancer, mainly by altering apoptosis, the cell cycle, and angiogenesis and inhibiting metastasis. Genistein
  6. BCC4762 Azathioprine Azathioprine(Azasan, Imuran; BW 57-322) is a drug that suppresses the immune system and is used in organ transplantation and autoimmune disease. Azathioprine
  7. BCC5088 Beta-Lapachone β-Lapachone (ARQ-501;NSC-26326) is a naturally occurring O-naphthoquinone, acts as a topoisomerase I inhibitor, and induces apoptosis by inhibiting cell cycle progression. Beta-Lapachone
  8. BCN5533 Ellagic acid Ellagic acid is a natural antioxidant, and acts as a potent and ATP-competitive CK2 inhibitor, with an IC50 of 40 nM and a Ki of 20 nM. Ellagic acid
  9. BCC1185 Cyclophosphamide Cyclophosphamide is a synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic activity, a immunosuppressant. Cyclophosphamide
  10. BCC1186 Mercaptopurine (6-MP) 6-Mercaptopurine is a purine analogue which acts as an antagonist of the endogenous purines and has been widely used as antileukemic agent and immunosuppressive drug. Mercaptopurine (6-MP)
  11. BCC1187 Floxuridine Floxuridine (5-Fluorouracil 2'-deoxyriboside) is a pyrimidine analog and known as an oncology antimetabolite. Floxuridine inhibits Poly(ADP-Ribose) polymerase and induces DNA damage by activating the ATM and ATR checkpoint signaling pathways in vitro. Floxuridine is a extreamly potent inhibitor for S. aureus infection and induces cell apoptosis. Floxuridine has antiviral effects against HSV and CMV. Floxuridine
  12. BCC4309 Amsacrine Amsacrine (m-AMSA; acridinyl anisidide) is an inhibitor of topoisomerase II, and acts as an antineoplastic agent which can intercalates into the DNA of tumor cells. Amsacrine
  13. BCC7665 Ellipticine Ellipticine (NSC 71795) is a potent antineoplastic agent; inhibits DNA topoisomerase II activities. Ellipticine
  14. BCC5354 Thio-TEPA Thio-TEPA is a DNA alkylating agent, with antitumor activity. Thio-TEPA
  15. BCC1592 Genz-644282 Genz-644282 is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity(IC50=1.2 nM). Genz-644282
  16. BCC2428 Tubacin Tubacin is a potent and selective inhibitor of HDAC6, with an IC50 value of 4 nM and approximately 350-fold selectivity over HDAC1. Tubacin
  17. BCC4310 Amsacrine hydrochloride Amsacrine hydrochloride (m-AMSA hydrochloride; acridinyl anisidide hydrochloride) is an inhibitor of topoisomerase II, and acts as an antineoplastic agent which can intercalates into the DNA of tumor cells. Amsacrine hydrochloride
  18. BCC3742 Busulfan Busulfan is a cell cycle non-specific alkylating antineoplastic agent. Busulfan
  19. BCN5740 Costunolide Costunolide, a sesquiterpene lactone, exhibits anti-inflammatory and anti-oxidant properties and mediates apoptosis. Costunolide
  20. BCC1521 Deferasirox Fe3+ chelate Deferasirox Fe3+ chelate (Exjade) is a rationally-designed oral iron chelator; its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. Deferasirox Fe3+ chelate
  21. BCC1192 Epirubicin HCl Epirubicin hydrochloride (4'-Epidoxorubicin hydrochloride), a semisynthetic L-arabino derivative of doxorubicin, has an antineoplastic agent by inhibiting Topoisomerase. Epirubicin hydrochloride is a Forkhead box protein p3 (Foxp3) inhibitor and inhibits regulatory T cell activity. Epirubicin HCl
  22. BCC1194 Idarubicin HCl Idarubicin hydrochloride is an anthracycline antileukemic drug. It inhibits the topoisomerase II interfering with the replication of DNA and RNA transcription. Idarubicin hydrochloride inhibits the growth of bacteria and yeasts. Idarubicin HCl
  23. BCC7860 Puromycin dihydrochloride Puromycin Dihydrochloride (CL13900 dihydrochloride), an aminonucleoside antibiotic, inhibits protein synthesis. Puromycin dihydrochloride
  24. BCN5796 Adenosine Adenosine is a nucleoside composed of a molecule of adenine attached to a ribose sugar molecule (ribofuranose) moiety via a β-N9-glycosidic bond. Adenosine
  25. BCN4090 Uridine Uridin is a glycosylated pyrimidine-analog containing uracil attached to a ribose ring (or more specifically, aribofuranose) via a β-N1-glycosidic bond. Uridine
  26. BCC2475 KU 55933 KU-55933 is a potent ATM inhibitor with an IC50 and Ki of 12.9 and 2.2 nM, respectively, and is highly selective for ATM as compared to DNA-PK, PI3K/PI4K, ATR and mTOR. KU 55933
  27. BCC3605 Trichostatin A (TSA) Trichostatin A (TSA) is a potent and specific inhibitor of HDAC class I/II, with an IC50 value of 1.8 nM for HDAC. Trichostatin A (TSA)
  28. BCC5293 5-BrdU 5-BrdU is a nucleoside analog that competes with thymidine for incorporation into DNA. 5-BrdU is commonly used in the detection of proliferating cells. 5-BrdU
  29. BCC3929 Acyclovir Acyclovir (Aciclovir) is a guanosine analogue and an orally active antiviral agent. Acyclovir inhibits HSV-1 (IC50 of 0.85 μM), HSV-2 (IC50 of 0.86 μM) and varicella-zoster virus. Acyclovir can be phosphorylated by viral thymidine kinase (TK), and Acyclovir triphosphate interferes with viral DNA polymerization through competitive inhibition with guanosine triphosphate and obligatory chain termination. Acyclovir prevents bacterial infections during induction therapy for acute leukaemia. Acyclovir
  30. BCC1214 Carmofur Carmofur is a derivative of fluorouracil, an antimetabolite used as an antineoplastic agent. Carmofur
  31. BCC3932 Oxaliplatin Oxaliplatin is a DNA synthesis inhibitor. Oxaliplatin causes DNA crosslinking damage, prevents DNA replication and transcription and causes cell death. Oxaliplatin time-dependently inhibits human melanoma cell lines C32 and G361 with IC50 values of 0.98 μM and 0.14 μM, respectively. Oxaliplatin induces cell autophagy. Oxaliplatin
  32. BCC7707 L189 L189 is a novel human DNA ligase inhibitor, inhibits hLigI/III/IV with IC50 of 5/9/5 μM. L189
  33. BCC1216 Altretamine Altretamine is an alkylating antineoplastic agent. Altretamine
  34. BCN3415 Cytidine Cytidine is a nucleoside molecule that is formed when cytosine is attached to a ribose ring, cytidine is a component of RNA. Cytidine
  35. BCC4162 Orotic acid Orotic acid (OA) is an intermediate in pyrimidine metabolism. Orotic acid
  36. BCN5918 4'-Demethylepipodophyllotoxin 4'-Demethylepipodophyllotoxin(4'-DMEP) is a key intermediate compound for the preparation of podophyllotoxin-type anti-cancer drugs; a potent inhibitor of microtubule assembly. 4'-Demethylepipodophyllotoxin
  37. BCC4116 Cytarabine hydrochloride Cytarabine hydrochloride, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine hydrochloride has antiviral effects against HSV. Cytarabine hydrochloride
  38. BCC1249 Amonafide Amonafide is a topoisomerase II inhibitor and DNA intercalator that induces apoptotic signaling by blocking the binding of Topo II to DNA. Amonafide
  39. BCC5109 CRT0044876 CRT0044876 is a potent and selective APE1 inhibitor with IC50 of ~3 μM. CRT0044876
  40. BCC5092 Pirarubicin Pirarubicin is an anthracycline antibiotics, acts as a topoisomerase II inhibitor, and is a widely used for treatment of various cancers, in particular, solid tumors. Pirarubicin
  41. BCC2146 Mocetinostat (MGCD0103, MG0103) Mocetinostat (MGCD0103) is a potent, orally active and isotype-selective HDAC (Class I/IV) inhibitor with IC50s of 0.15, 0.29, 1.66 and 0.59 μM for HDAC1, HDAC2, HDAC3 and HDAC11, respectively. Mocetinostat shows no inhibition on HDAC4, HDAC5, HDAC6, HDAC7, or HDAC8. Mocetinostat (MGCD0103, MG0103)
  42. BCC4450 Adenine Adenine is a purine derivative and a nucleobase with a variety of roles in biochemistry. Adenine
  43. BCC2150 ITF2357 (Givinostat) Givinostat hydrochloride monohydrate (ITF-2357 hydrochloride monohydrate) is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively. ITF2357 (Givinostat)
  44. BCC3681 Fludarabine Phosphate (Fludara) Fludarabine (phosphate) is an analogue of adenosine and deoxyadenosine, which is able to compete with dATP for incorporation into DNA and inhibit DNA synthesis. Fludarabine Phosphate (Fludara)
  45. BCC1476 CHAPS CHAPS is a zwitterionic nondenaturing detergent for solubilizing membrane proteins. CHAPS
  46. BCC1256 Leflunomide Leflunomide is a pyrimidine synthesis inhibitor, inhibiting dihydroorotate dehydrogenase, and acts as a disease-modifying antirheumatic drug. Leflunomide
  47. BCN4318 Camptothecin Camptothecin (Campathecin) is a potent DNA enzyme topoisomerase I inhibitor, with an IC50 of 679 nM. Camptothecin
  48. BCC2155 PCI-24781 (CRA-024781) Abexinostat (CRA 024781) is a novel pan-HDAC inhibitor mostly targeting HDAC1 with Ki of 7 nM. PCI-24781 (CRA-024781)
  49. BCC6507 6-Thio-dG 6-Thio-2'-Deoxyguanosine is a nucleoside analogue that can be incorporated into de novo-synthesized telomeres by telomerase. 6-Thio-dG
  50. BCC3848 Rifaximin (Xifaxan) Rifaximin(Xifaxan) is an orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. Rifaximin (Xifaxan)
  51. BCC2526 Ofloxacin Ofloxacin (Hoe-280) is a fluoroquinolone whose primary mechanism of action is inhibition of bacterial DNA gyrase. Ofloxacin
  52. BCC2422 NCH 51 PTACH (NCH-51) is a SAHA-based novel inhibitor of human HDAC. PTACH exerts potent growth inhibition against various human cancer cells, with EC50 values ranging from 1 to 10 μM. NCH 51
  53. BCC2151 MC1568 MC1568 is a selective class II (IIa) histone deacetylas (HDAC II) inhibitor, used for cancer research. MC1568
  54. BCC4386 Temozolomide Temozolomide (NSC 362856) is an oral active DNA alkylating agent that crosses the blood-brain barrier. Temozolomide is also a proautophagic and proapoptotic agent. Temozolomide is effective against tumor cells that are characterized by low levels of O6-alkylguanine DNA alkyltransferase (OGAT) and a functional mismatch repair system. Temozolomide has antitumor and antiangiogenic effects. Temozolomide
  55. BCC2165 Resminostat (RAS2410) Resminostat (RAS2410; 4SC-201) is a potent inhibitor of HDAC1, HDAC3 and HDAC6, with mean IC50 values of 42.5, 50.1, 71.8 nM, respectively, and shows less potent activities against HDAC8, with an IC50 of 877 nM. Resminostat (RAS2410)
  56. BCC6381 RX-3117 RX-3117(TV-1360; Fluorocyclopentenylcytosine) is novel a cytidine analog; shows anticancer activity in several cancer cell lines, including gemcitabine-resistant variants. RX-3117
  57. BCC2147 JNJ-26481585 Quisinostat (JNJ-26481585) is an orally available, potent HDAC inhibitor with IC50s of 0.11 nM, 0.33 nM, 0.64 nM, 0.46 nM, and 0.37 nM for HDAC1, HDAC2, HDAC4, HDAC10, HDAC11, respectively. JNJ-26481585
  58. BCC4060 LY2334737 LY2334737 is an nucleoside analog and is an orally active prodrug of Gemcitabine. LY2334737 exhibits inhibitory activity against enterovirus A71 (EV-A71) infection. LY2334737 has antiviral and anticancer effects. LY2334737
  59. BCC5580 BMH-21 BMH-21 is a small molecule DNA intercalator that binds ribosomal DNA and inhibits RNA polymerase I (Pol I) transcription; does not cause phosphorylation of H2AX. BMH-21
  60. BCC3694 Bleomycin Sulfate Bleomycin sulfate is a DNA synthesis inhibitor with potent antitumor activity. Bleomycin Sulfate
  61. BCC3911 CGK733 CGK733 is a potent ATM/ATR inhibitor, used for the research of cancer. CGK733
  62. BCC1998 TH-302 Evofosfamide (TH-302) is a hypoxia-activated prodrug with IC50 of 10 μM and 1000 μM in hypoxia (N2) and normoxia (21% O2), respectively. TH-302
  63. BCC3699 KU-60019 KU-60019 is an improved analogue of KU-55933, with IC50 of 6.3 nM for ATM in cell-free assays, 270- and 1600-fold more selective for ATM than DNA-PK and ATR,and is a highly effective radiosensitizer. KU-60019
  64. BCC6489 MN 64 MN-64 is a potent tankyrase 1 inhibitor, with IC50s of 6 nM, 72 nM, 19.1 μM, and 39.4 μM for TNKS1, TNKS2, ARTD1 and ARTD2, respectively. MN 64
  65. BCC2152 Pracinostat (SB939) Pracinostat is a potent histone deacetylase (HDAC) inhibitor, with IC50s of 40-140 nM, used for cancer research. Pracinostat (SB939)
  66. BCC2161 AR-42 (OSU-HDAC42) AR-42 is an HDAC inhibitor with IC50 of 30 nM. Phase 1. AR-42 (OSU-HDAC42)
  67. BCC2426 TC-H 106 Pimelic Diphenylamide 106 is a slow, tight-binding inhibitor of class I HDAC (HDAC 1, 2, and 3, with IC50 values of 150 nM , 760nM, and 370 nM, respectively), demonstrating no activity against class II HDACs. TC-H 106
  68. BCC2420 KD 5170 KD 5170
  69. BCC3784 Gemcitabine Gemcitabine (LY 188011) is a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent. Gemcitabine inhibits DNA synthesis and repair, resulting in autophagyand apoptosis. Gemcitabine inhibits the growth of BxPC-3, Mia Paca-2, PANC-1, PL-45 and AsPC-1 cells with IC50s of 37.6 nM, 42.9 nM, 92.7 nM, 89.3 nM and 131.4 nM, respectively. Gemcitabine
  70. BCC2148 PCI-34051 PCI-34051 is a potent and selective HDAC8 inhibitor with IC50 of 10 nM, with >200-fold selectivity over the other HDAC isoforms. PCI-34051
  71. BCC2427 TCS HDAC6 20b Selective HDAC6 inhibitor TCS HDAC6 20b
  72. BCC2490 Irinotecan Irinotecan is a topoisomerase I inhibitor, preventing religation of the DNA strand by binding to topoisomerase I-DNA complex. Irinotecan
  73. BCC5635 Penciclovir Sodium Penciclovir Sodium
  74. BCC4260 Valproic acid Valproic acid (VPA; 2-Propylpentanoic Acid) is an HDAC inhibitor, with IC50 in the range of 0.5 and 2 mM, also inhibits HDAC1 (IC50, 400 μM), and induces proteasomal degradation of HDAC2. Valproic acid activates Notch1 signaling and inhibits proliferation in small cell lung cancer (SCLC) cells. Valproic acid sodium salt is used in the treatment of epilepsy, bipolar disorder and prevention of migraine headaches. Valproic acid
  75. BCC2157 Droxinostat Droxinostat(NS41080) is a selective inhibitor of HDAC3, HDAC6, and HDAC8 with IC50 of 16.9, 2.47 and 1.46 μM, respectively; > 8-fold selective against HDAC3 and no inhibition to HDAC1, 2, 4, 5, 7, 9, and 10. Droxinostat

Items 101 to 174 of 174 total

     
  1. First
  2.  
  3.  
  4. 1
  5. 2
  6.